Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in Glioblastoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-0926
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Multiple Mutations and Bypass Mechanisms Can Contribute to Development of Acquired Resistance to MET Inhibitors

Cancer Research
Cancer ResearchOncology
2011English

Neuroblastoma: Oncogenic Mechanisms and Therapeutic Exploitation of Necroptosis

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2015English

Mechanisms of Cell Resistance in Glioblastoma Multiforme

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2010English

Anti-Met VHH Pool Overcomes MET-targeted Cancer Therapeutic Resistance

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Influenza Polymerase Inhibitors: Mechanisms of Action and Resistance

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Resistance Mechanisms in Melanoma to Immuneoncologic Therapy With Checkpoint Inhibitors

2019English

Influenza Neuraminidase Inhibitors: Antiviral Action and Mechanisms of Resistance

Influenza and other Respiratory Viruses
EnvironmentalPublic HealthEpidemiologyPulmonaryInfectious DiseasesRespiratory MedicineOccupational Health
2012English

Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer

International Journal of Breast Cancer
Cancer ResearchOncologyPharmacology
2012English

Elucidating the Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer Patients

Canadian Journal of Biotechnology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy